Skip to main content
. 2023 Aug 30;2023(8):CD009365. doi: 10.1002/14651858.CD009365.pub2

Gilbert 1985.

Study characteristics
Methods Study design: RCT
Recruitment period: not reported, duration 10 months
Recruitment mode: all people who presented with LBP to 22 participating family physicians. Physicians were drawn from both single‐handed and group practices, worked predominantly in urban areas, and cared for an average of 2000 patients.
Statistical analysis: ANOVA controlling for baseline measures to assess patient diary outcomes and survival analysis (Cox proportional hazards model)
Sample size calculation: based upon determining a clinically important difference of 1 SD on the activity discomfort scale
Participants Sample size: total: 252; EG1: 65, EG2: 62, CG1: 60, CG2: 65
Setting: primary care, family practice
Country: Canada
Baseline characteristics
  • Age in years, mean (SD): EG1: 40.7 (14); EG2: 41.7 (15.3); CG1: 40.0 (14.9); CG2: 40.1 (14.5)

  • Sex, number (%) women: EG1: 33 women (51%); EG2: 33 women (53%); CG1: 30 women (50%); CG2: 28 women (43%)


Duration LBP: (<6 days versus ≥ 6 days): EG1: 41 versus 24; EG2: 30 versus 32; CG1: 29 versus 31; CG2: 35 versus 30
Inclusion criteria
  • Over 16 years of age

  • Complaining of lumbosacral pain (with or without radiating pain in the lower extremity)

  • Free of pain for at least 30 days prior to the current episode


Exclusion criteria
  • Subjects had abnormal sensation, motor power, or reflexes

  • If the subjects' symptoms were proven to be due to fractures

  • Pregnancy

  • Spondylolisthesis

  • Spinal infection

  • Disease of the hip or pelvis

  • Gastrointestinal disease

  • Tumour

  • Paget's disease

  • Rheumatic disease

Interventions EG1: exercise and education plus bed rest
  • Description: isometric flexion exercise, advice to repeat exercises at home 3 times a day

  • Materials/equipment: not reported

  • Non‐exercise component: 4 days bed rest, education (20 minutes presentation on back care + information sheet), analgesic

  • Frequency and duration: repeat visits as necessary, otherwise not reported

  • Delivery: partially independent, individual supervised generic sessions and unsupervised home programme component

  • Provider: PT


EG2: exercise and education alone
  • Description: isometric flexion exercise, advice to repeat exercises at home 3 times per day

  • Materials/equipment: not reported

  • Non‐exercise component: education (20 minutes presentation on back care + information sheet), analgesic

  • Frequency and duration: repeat visits as necessary

  • Delivery: partially independent, individual supervised generic sessions and unsupervised home programme component

  • Provider: PT


CG1: bed rest
  • 4 days' bed rest, analgesics


CG2
  • Analgesics, no other treatment

Outcomes Note: outcomes were not defined as major or minor
Pain: MPQ (0–78)
  • Baseline, mean (SD): EG1: 23.0 (7.4); CG1: 25.2 (8.6); EG2: 22.7 (6.7); CG2: 25.1 (6.9)

  • 6 weeks, mean (SD): EG1: 22.7 (6.7); CG1 25.2 (8.6); EG2: 23 (7.4); CG2: 25.1 (6.9)

  • Follow‐up, mean (SD): EG1: 7.5 (1.2); CG1: 7.9 (2.0); EG2: 8.4 (0.9); CG2: 8.6 (1.3)


In the meta‐analyses, all values are multiplied by 1.28 to convert to a 0–100 scale
Functional status: ADS (0–78)
  • Baseline measure: no

  • 6 weeks, mean (SD): EG1: 35.9 (13.7); CG1: 36.3 (13.1); EG2: 40.4 (16.4); CG2: 36.6 (12.4)

  • Follow‐up, mean (SD): EG1: 24.4 (8.8); CG1: 24.3 (9.2); EG2: 21.3 (10.0); CG2: 20.9 (8.5)


In the meta‐analyses, all values are multiplied by 1.28 to convert to a 0–100 scale
Perceived recovery: pain no worse than mild according to participant and physician
  • 6 weeks, number recovered/total: EG1: 48/61; CG1: 44/56; EG2: 48/60; CG2: 42/58

  • 12 weeks, number recovered/total: EG1: 53/63; CG1: 49/57; EG2: 54/62; CG2: 53/60


Other: medication use for their LBP and any other measures that they used to alleviate the pain, bed rest was monitored with an integrated motor activity monitor
At 1 year of follow‐up: frequency and severity of any episode of LBP, current activity level, and if they had seen a professional for their LBP
Adverse events: not reported
Notes Authors' results and conclusions: no beneficial effect of either treatment was observed on clinical outcome measures
Funding: funded by Ontario Ministry of Health (DM 500; Governmental)
Declaration of interest: no conflicts of interest reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Quote: "After obtaining informed consent the physicians telephoned a centralised patient registry and randomisation service in the department of epidemiology and biostatistics, Mc. Master University. Patients were stratified within each practice by whether their physician intended to place them on minor or major medications. Within each strata, patients were randomly assigned to one of four treatment groups."
No further text on how the sequence was generated.
Allocation concealment (selection bias) Unclear risk Unclear who was responsible for allocation and if this person could foresee the assignment.
Blinding
All outcomes ‐ Participants High risk No mention of any attempts to blind participants to other interventions, treatment allocation, or their perceptions of the potential effectiveness of the different interventions.
Blinding
All outcomes ‐ Healthcare providers High risk No mention of any attempts to blind the study physiotherapist. The physician was blind to the participant's assigned treatment.
Blinding
All outcomes ‐ outcome assessors High risk The outcome measures were self‐reported and participants were unblinded.
Influence of co‐interventions Low risk Co‐interventions were similar among treatment groups.
Group similarity at baseline Low risk The 4 treatment groups were well balanced on 13 key variables. Some significant and clinically important differences were observed. Participants randomised to the educational programme were better at baseline on 3 measures. These baseline differences were taken into account in the analyses.
Compliance Low risk Compliance with bed rest, exercise, and back care techniques were measured by means of a diary in which all participants recorded the time they spent resting and exercising every day, their daily activities, and any restrictions. 89% of participants completed at least one 10‐day patient diary.
Participants in the exercise group also reported to the research assistant at the 6‐ and 12‐week telephone interviews the extent to which they continued to follow the exercise and back care program.
Activity monitors (worn on the wrist to record body movement) were used by randomly selected participants to obtain an objective measure of daily activity. However, the monitors proved to be unreliable and thus no objective measure of compliance with bed rest could be obtained. Compliance with physiotherapy was determined in part by participants returning for their physiotherapy education. All but 2 of the participants randomised to physiotherapy and education saw the physiotherapist at least once, and no participants in the non‐physiotherapist groups received the physiotherapy and education programme.
Timing of outcome assessments Low risk During the intervention each time participants visited the GP (with a 10‐day interval until the pain had subsided); and at 6 and 12 weeks, and 12 months after the participant's entry into the project. All important outcomes were measured at the same time across groups.
Incomplete outcome data (attrition bias)
Dropouts – all outcomes Low risk Some participants dropped out. 87% returned to their physician for follow‐up evaluation. A telephone follow‐up was completed for 96% of participants at 6 and 12 weeks and for 90% at 1 year.
Intention‐to‐treat‐analysis High risk 10 participants were excluded from the analysis because they did not undergo the assigned therapy. 8 participants were excluded because they did not fulfil the eligibility criteria.
Selective reporting (reporting bias) Low risk A study protocol is not available, but all prespecified outcomes and important outcome measures in LBP research were reported: pain (MPQ), function (ADS), perceived recovery.
Other bias Unclear risk Governmental funding. No official disclosure regarding potential conflicts of interest.